News
Press releases, milestones, and coverage from Camillus Capital and the companies we back.
Coverage & Updates
TechCrunch · April 22nd 2026
10X Science featured in TechCrunch on making sense of AI-generated drug candidates
TechCrunch profiled portfolio company 10X Science, whose platform helps pharma researchers characterize the surge of drug candidates AI models are now producing, using mass spectrometry data to identify which ones are worth pursuing.
Portfolio News
-
Harbinger Health Closes $100M Round for Blood-Based Cancer Detection
Flagship Pioneering-backed Harbinger Health raised $100M to launch Resolve, its new multi-cancer blood test aimed at earlier diagnosis.
April 14, 2026
-
EnPlusOne Biosciences Showcases Advances in Its ezRNA Enzymatic RNA Synthesis Platform
EnPlusOne showcased improvements to its enzymatic RNA synthesis platform, ezRNA™, including greater yield, purity, and access to novel RNA modifications.
May 12, 2026
-
GSK Expands AI Drug Discovery Partnership with Relation Therapeutics in $110M Deal
GSK and Relation Therapeutics deepened their collaboration in a deal worth up to $110 million, using AI foundation models trained on large-scale cell-response data to identify new drug targets.
July 30, 2026
-
Albotherm Awarded UK Patent for Temperature-Responsive Coating Technology
Albotherm's newly patented microcapsule technology reflects heat in hot weather and turns clear as temperatures cool, protecting crops and buildings from overheating while preserving light.
March 27, 2026
-
Oxford Immune Algorithmics Launches Algocyte Proxima, an AI-Powered At-Home Blood Testing Analyser
Oxford Immune Algorithmics introduced Algocyte Proxima, a portable at-home haematology analyser using AI to support earlier detection and ongoing monitoring of blood and autoimmune conditions.
June 29, 2026